Colgate-Palmolive Company

New York, NY ManufacturingNAICS 325600

Self-funded health planPlan year 2025Renews JanuaryCollectively bargained
8,181Participants0% vs. prior year
$19.4MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#3 of 45Manufacturing in NYBy participants

Overview

Colgate-Palmolive Company sponsors a self-funded health plan that covered 8,181 participants in plan year 2025, about the same as the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
8,181 · prior year 8,195
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Colgate-Palmolive Company Employee Prescription Drug Plan, plan 503 (8,181 participants); Colgate-Palmolive Company Retiree Medical Plan, plan 526 (3,258 participants)
Broker compensation
$948K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Hartford Life and AccidentLife14,600$9.5M$493K
Metropolitan Life Insurance CompanyMedical, Short-term disability, Long-term disability5,673$3.9M$270K
Connecticut General Life Insurance CompanyMedical, Dental486$2.4M—
Eyemed Vision CareVision7,474$1.1M$108K
Prudential Insurance Company of AmericaLong Term Care380$778K$27K
Metropolitan General Insurance CompanyLegal1,086$215K$26K
Ace American Insurance CompanyAccidental Death and Dismemberment32,215$81K$24K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$19.4M/ year

Estimated prescription spend: 8,181 participants × $2,371 national average per member. Usually higher once dependents are counted.

$504K–$1.2M/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$147K–$369K
Lower-cost therapeutic alternatives$215K–$450K
Generic pricing vs. actual cost$93K–$279K
PBM contract terms$48K–$145K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Colgate-Palmolive Company
Sponsor EIN
13-1815595
Plan numbers
503, 526
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 13-1815595 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Colgate-Palmolive Company Employees Savings & Investment Plan
Type
401(k) plan
Participants
8,877

About this data

Source: Colgate-Palmolive Company's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Colgate-Palmolive Company.

Request a correction · Methodology